Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide

Journal of Peptide Science

Volumn 16, Issue 4, 2010, Pages 171-177

  Ando, Setsuko ^a   Mitsuyasu, Keitarou ^a   Soeda, Yoshitake ^a   Hidaka, Mariko ^a   Ito, Yuki ^a   Matsubara, Kouki ^a   Shindo, Mitsuno ^b   Uchida, Yoshiki ^b   Aoyagi, Haruhiko ^c  

^a FUKUOKA UNIVERSITY   (Japan)

^b OSAKA SHOIN WOMEN'S UNIVERSITY   (Japan)

^c KYUSHU NUTRITION WELFARE UNIVERSITY   (Japan)

Author keywords

Antibiotic activity; Antimicrobial peptide; Hemolytic activity; Indolicidin; Retro peptide

Indexed keywords

ARGININE; INDOLICIDIN; INDOLICIDIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPTOPHAN;

NEGIBACTERIA; POSIBACTERIA;

EID: 77949755883     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1217     Document Type: Article

References (36)

1. Boman HG. Peptide antibiotics: holy or heretic grails of innate immunity? Scand. J. Immunol. 1996; 43: 475-482.
2. Ganz T, Lehrer RI. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 1998; 10: 41-44.
3. Saberwal G, Nagaraj R. Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes: facets of their conformational features, structure-function correlations and membrane perturbing activities. Biochim. Biophys. Acta 1994; 1197: 109-131.
4. Tossi A, Sandri L, Giangaspero A. Amphipathic, α-helical antimicrobial peptides. Biopolymers 2000; 55: 4-30.
5. Deber CM, Li S-C. Peptides in membranes: helicity and hydrophobicity. Biopolymers 1995; 37: 295-318.
6. Shai Y, Oren Z. From 'carpet' mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 2001; 22: 1629-1641.
7. Dathe M, Meyer J, Beyerman M, Maul B, Hoischen C, Bienert M. General aspect of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphiphilic helical model peptides. Biochim. Biophys. Acta 2002; 1558: 171-186.
8. Hancock REW. Peptide antibiotics. Lancet 1997; 349: 418-422.
9. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin-isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 5449-5453.
10. Klüver E, Adermann K, Schulz A. Synthesis and structure-activity relationship of β-defensins,multi-functional peptides of the immune system. J. Pept. Sci. 2006; 12: 243-257.
11. Niidome T, Kobayashi K, Arakawa H, Hatakeyama T, Aoyagi H. Structure-activity relationship ofanantibacterialpeptide,maculatin 1.1, from the skin glands of the tree frog, Litoria genimaculata. J. Pept. Sci. 2004; 10: 414-422.
12. Koo YS, Kim JM, Park IY, Yu BJ, Jang SA, Kim K-S, Park CB, Cho JH, Kim SC. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide. Peptides 2008; 29: 1102-1108.
13. Selsted ME, Novotny MJ, Morris WL, Tang YQ, Smith W, Cullor JS. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 1992; 267: 4292-4295.
14. Lehrer RI, Lichtenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 1993; 11: 109-128.
15. Saberwal G, Nagaraj R. Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes: facets of their conformational features, structure-function correlations and membrane-perturbing abilities. Biochim. Biophys. Acta 1994; 1197: 109-132.
16. Boman HG. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 1995; 13: 61-62.
17. Blondelle SE, Houghten RA. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry 1992; 31: 12688-12694.
18. Yang S-T, Shin SY, Hahm K-S, Kim JI. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities. Int. J. Antimicrob. Agents 2006; 27: 325-330.
19. Chan DI, Prenner EJ, Vogel HJ. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 2006; 1758: 1184-1202.
20. Khandelia H, Kaznessis YN. Cation-π interactions stabilize the structure of the antimicrobial peptide indolicidin near membranes: moleculardynamics simulations. J.Phys.Chem.B 2007;111:242-250.
21. Shaw JE, Alattia J-R, Verity JE, Prive GG, Yip CM. Mechanisms of antimicrobial peptide action: studies of Indolicidin assembly at model membrane interfaces by in situ atomic force microscopy. J. Struct. Biol. 2006; 154: 42-58.
22. Ahmad I, Perkins WR, Lupan DM, Selsted ME, Janoff AS. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochim. Biophys. Acta 1995; 1237: 109-114.
23. Uchida Y, Shindo M, Otani T. In Peptide Chemistry 1995, NishiN (ed.). Protein Research Foundation: Osaka, 1996; 229-232.
24. Subbalakshmi C, Bikshapathy E, Sitaram N, Nagaraj R. Antibacterial and hemolytic activities of single tryptophan analogs of indolicidin. Biochem. Biophys. Res. Commun. 2000; 274: 714-716.
25. Ryge TS, Doisy X, Ifrah D, Olsen JE, Hansen PR. New indolicidin analogues with potent antibacterial activity. J. Pept. Res. 2004; 64: 171-185.
26. Zhang L,Rozek A,Hancock REW.Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 2001; 276: 35714-35722.
27. Friedrich CL, Rozek A, Patrzykat A, Hancock REW. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J Biol Chem 2001; 276: 24015-24022.
28. Park KH, Park Y, Park IS, Hahm KS, Shin SY. Bacterial selectivity and plausible mode of antibacterial action of designed Pro-rich short model antimicrobial peptides. J Pept. Sci. 2008; 14: 876-882.
29. Ando S, Mitsuyasu K, Soeda Y, Hidaka M, Ito Y, Shindo M, Uchida Y, Nishikawa H. Synthesis and biological activities of indolicidin analogs. Fukuka Univ. Sci. Rep. 2006; 36: 7-13.
30. Nagpal S, Kaur KJ, Jain D, Salunke DM. Plasticity in structure and interactions is critical for the action of indolicidin, an antibacterial peptide of innate immune origin. Protein Sci. 2002; 11: 2158-2167.
31. Yoshida K, Mukai Y, Niidome T, Takashi C, Tokunaga Y, Hatakeyama T, Aoyagi H. Interaction of pleurocidin and its analogs with phospholipids membrane and their antibacterial activity. J. Pept. Res. 2001; 57: 119-126.
32. Izumiya N, Kato T, Aoyagi H, Waki M, Kondo M. Synthetic Aspects of Biologically Active Cyclic Peptides, Gramicidin S and Tyrocidines. Kodansha: Tokyo, 1979.
33. Lisowski M, Olczak J, Zabrocki J. Circular dichroic properties of the tyrosine residues in tetrazole analogues of opioid peptides. J. Pept. Sci. 2006; 12: 297-302.
34. Ladokhin AS, Selsted ME, White SH. CD spectra of indolicidin antimicrobial peptides suggest turns, not polyproline helix. Biochemistry 1999; 38: 12313-12319.
35. Andrushchenko VV, Vogel HJ, Prenner EJ. Solvent-dependent structure of two tryptophan-rich antimicrobial peptides and their analogs studied by FTIR and CD specrtoscopy. Biochim. Biophys. Acta 2006; 1758: 1596-1608.
36. Ando S, Nishikawa H, Takiguchi H, Lee S, Sugihara G. Antimicrobial specificity and hemolytic activity of cyclized basic amphiphilic β-structuralmodelpeptidesandtheir interactionswithphospholipid bilayers. Biochim. Biophys. Acta 1993; 1147: 42-49.